Peter C. Lucas

机构：Mayo Clinic, University of Pittsburgh, WinnMed, Magee-Womens Research Institute, Mayo Clinic in Arizona, Cancer Research Center, UPMC Hillman Cancer Center, Mayo Clinic in Florida · ORCID：0000-0003-4880-7172

发表论文 438 篇 · 总被引 14664 次 · h-index 57

代表论文

• p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy (2025 · Nature Cancer · 被引 13)
• Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women (2026 · Nature Aging · 被引 2)
• Estrogen receptor-positive cell line xenograft models recapitulate metastatic dissemination and endocrine response of invasive lobular breast carcinoma (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency) (2026 · Mayo Clinic Proceedings · 被引 1)
• MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression in mice (2026 · Nature Communications)
• Novel transplantable mouse cell line model recapitulates invasive lobular breast carcinoma (ILC) phenotype and immune microenvironment. (2026 · bioRxiv (Cold Spring Harbor Laboratory))